ANI
18 May 2021, 06:48 GMT+10
Tokyo [Japan] May 18 (ANI): Japan's health ministry is set to authorize the use of Moderna's coronavirus vaccine later this week.
Currently, the Pfizer vaccine is the only one being used as Japan inoculates the elderly and others. Applications for the Moderna and AstraZeneca vaccines have been filed with the ministry, following Pfizer's, as reported by NHK World Japan.
The ministry will convene a meeting of experts on Thursday to look into both vaccines. The ministry will likely give the green light to Moderna as early as Friday, after gaining approval from the experts.
The Moderna vaccine is then expected to be administered at mass vaccination sites due to open on Monday next week.
As for the AstraZeneca vaccine, ministry officials will carefully weigh its alleged risk of forming blood clots against the efficacy, with input from the experts in mind.
Under a contract with Japan's government, AstraZeneca will supply enough doses for 60 million people.
The European Medicines Agency (EMA) has allowed the storage of the Pfizer/BioNTech vaccine against the coronavirus in normal fridge conditions, at 35 to 46 degrees Fahrenheit, for up to 31 days.
According to initial demands from manufacturers, the Pfizer/BioNTech vaccine had to be stored at ultra-cold temperatures between -80 to -60 degrees Celsius (-112 to -76 degrees Fahrenheit). EMA's human medicines committee (CHMP) has recommended a change to the approved storage conditions, EMA said on Monday to Sputnik.
The accessibility of vaccines will help in stopping the spread in such a massive number.
The Pfizer/BioNTech and Moderna coronavirus vaccines appear to protect against COVID variants B.1.617 and B.1.618 first identified in India, researchers have reported in a new pre-print paper, which has not yet been peer-reviewed, CNN reported.
Based on lab experiments involving cell cultures, the B.1.617 and B.1.618 variants seem to be partially resistant to the antibodies elicited by vaccination, according to the pre-print paper posted to the online server biorxiv.org on Sunday.
"Thus, there is a good reason to believe that vaccinated individuals will remain protected against the B.1.617 and B.1.618 variants," the researchers from New York University wrote in their paper. But more research is needed to determine just how effective the Pfizer/BioNTech and Moderna vaccines are against those variants in the real world.
Moreover, the World Health Organization (WHO) has classified the coronavirus variant first found in India as a "variant of global concern".It said studies show the B.1.617 mutation spreads more easily than other variants and requires further study, CNN reported.
The new research involved serum samples collected from eight people who recovered from Covid-19, six people fully vaccinated with the Pfizer/BioNTech vaccine and three people fully vaccinated with Moderna's vaccine. The researchers analyzed in lab experiments how the serum samples neutralized lentiviruses -- a type of retrovirus -- equipped with the same mutations as the B.1.617 and B.1.618 coronavirus variants.
(ANI)Get a daily dose of Dublin News news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Dublin News.
More InformationNEW YORK, New York - U.S. stock markets closed firmly in positive territory to start the week Monday, with the S&P 500 and Dow Jones...
WASHINGTON, D.C.: On Friday, President Donald Trump announced that he was halting trade discussions with Canada due to its decision...
LONDON, U.K.: A little-known investment fund based in the United Arab Emirates has emerged as the most prominent public backer of U.S....
SAN FRANCISCO, California: Across the U.S., a growing number of people are taking obesity treatment into their own hands — literally....
SAN FRANCISCO, California: Under pressure from European regulators, Apple has revamped its App Store policies in the EU, introducing...
NEW YORK CITY, New York: The U.S. dollar tumbled this week, hitting its lowest levels since 2021 against the euro, British pound, and...
FRANKFURT, Germany: Germany has become the latest country to challenge Chinese AI firm DeepSeek over its data practices, as pressure...
DUBLIN, Ireland: Ireland's EU Commissioner Michael McGrath has defended Commission Vice President Kaja Kallas over her recent comments...
SAN FRANCISCO, California: Under pressure from European regulators, Apple has revamped its App Store policies in the EU, introducing...
BONN, Germany: Despite widespread belt-tightening across the United Nations, nearly 200 countries agreed this week to increase the...
DUBLIN, Ireland: Post-tax profits at Ballymaloe Cookery School rose by 53 percent in 2024 to 135,952 euros, helped by the buzz around...
DUBLIN, Ireland: A 63-year-old woman, Sigrid O'Meara from Ballincurry, Longford, is suing Boots Pharmacy in the High Court. She says...